PARP1 (PARP1) antibody
| Antigen |
|
| Synonyms |
PARP, PPOL, ADPRT, ADPRT1, PARP-1, pADPRT-1 |
| Clonality |
Monoclonal |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
Alternatives Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Flow Cytometry (FACS)
|
| Catalog no. |
ABIN650219 |
| Quantity |
100ul (Variants) |
| Price |
450.00 $ Plus shipping costs $45.00
|
|
Bulk discount
|
| Shipping to |
|
| Availability |
Will be delivered in 2 to 3 Business Days |
|
Alternative name
|
PARP-1 (p116/p25)
|
|
Gene ID
|
142
|
|
UniProt
|
P09874
|
|
Immunogen
|
A synthetic peptide corresponding to N-terminal residues of human PARP-1 was used as immunogen. The antibody should recognize both pro-form and p25 cleaved-form of PARP-1.
|
|
Description
|
Other names: PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADPRT,NAD(+) ADP-ribosyltransferase 1,Poly[ADP-ribose] synthetase 1
|
|
Characteristics
|
Rabbit Monoclonal Antibody
|
|
Specificity
|
A synthetic peptide corresponding to N-terminal residues of human PARP-1 was used as immunogen. The antibody should recognize both pro-form and p25 cleaved-form of PARP-1.
|
|
Molecular Weight
|
116/25 kDA
|
|
Comments
|
Background: Poly (ADP-ribose) polymerase (PARP) is zinc-dependent DNA binding protein that recognizes DNA strand breaks and is presumed to play a role in DNA repair (1). As a marker for apoptosis, PARP is cleaved in vitro by many caspases, and in vivo by Caspase-3 (2,3). Existing as a 116 kDa nuclear protein, PARP is cleaved between amino acids Asp214 and Gly215 to yield two fragments of 29 kDa (C-terminal catalytic domain) and 85 kDa (N-terminal DNA-binding domain) (2,4).
|
|
Product
|
Tewari, Quan, ORourke et al.: "Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase." in: Cell, Vol. 81, Issue 5, pp. 801-9, 1995 (PubMed).
Kaufmann, Desnoyers, Ottaviano et al.: "Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis." in: Cancer research, Vol. 53, Issue 17, pp. 3976-85, 1993 (PubMed).
|
Alternatives for antigen "PARP1 (PARP1)", type "Antibodies"